Quarterly report · Q2
3645.TEDINET S100SMIQ
Period2023-06-01 → 2023-11-30
Filed2024-01-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.3bn | 2023-06-01 → 2023-11-30 | Cons. | Net sales |
| Revenue | ¥4.5bn | 2022-06-01 → 2023-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.0bn | 2022-06-01 → 2022-11-30 | Cons. | Net sales |
| Operating income | ¥170m | 2023-06-01 → 2023-11-30 | Cons. | Operating income |
| Operating income | ¥178m | 2022-06-01 → 2022-11-30 | Cons. | Operating income |
| Ordinary income | ¥194m | 2023-06-01 → 2023-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥432m | 2022-06-01 → 2023-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥205m | 2022-06-01 → 2022-11-30 | Cons. | Ordinary income |
| Profit before tax | ¥192m | 2023-06-01 → 2023-11-30 | Cons. | Income before income taxes |
| Profit before tax | ¥207m | 2022-06-01 → 2022-11-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥116m | 2023-06-01 → 2023-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥116m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥116m | 2022-06-01 → 2022-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥126m | 2023-06-01 → 2023-11-30 | Cons. | Profit loss |
| Net income | ¥130m | 2022-06-01 → 2022-11-30 | Cons. | Profit loss |
| Total assets | ¥3.6bn | at 2023-11-30 | Cons. | Assets |
| Total assets | ¥3.5bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥3.4bn | at 2022-11-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.5bn | at 2023-11-30 | Cons. | Liabilities |
| Total liabilities | ¥1.5bn | at 2023-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.0bn | at 2023-11-30 | Cons. | Net assets |
| Net assets / equity | ¥1.9bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥1.9bn | at 2022-11-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.4bn | at 2023-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.5bn | at 2023-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.4bn | at 2023-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2023-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2022-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2022-05-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥131m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥429m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥59m | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥14m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥62m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥32m | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥14m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥18m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥906,000 | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥12.8 | 2023-06-01 → 2023-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.39 | 2023-09-01 → 2023-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.97 | 2022-06-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥13.09 | 2022-06-01 → 2022-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.36 | 2022-09-01 → 2022-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 56.4% | at 2023-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.3% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.8% | at 2022-11-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-06-01 → 2023-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-06-01 → 2023-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-06-01 → 2023-11-30 | ¥2m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥562m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥562m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥315m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥70m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥70m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥7,000 |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥7m |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥1.7bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥1.7bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥68m |
| —segment total | revenue | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| —segment total | revenue external | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| —segment total | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥7,000 |
| —segment total | segment profit | 2023-06-01 → 2023-11-30 | ¥390m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥7,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-06-01 → 2023-11-30 | ¥392m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-06-01 → 2022-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-06-01 → 2022-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-06-01 → 2022-11-30 | ¥2m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥499m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥499m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥2,000 |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥297m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥83m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥83m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥12,000 |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥25m |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥1.4bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥1.4bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥213,000 |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥51m |
| —segment total | revenue | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| —segment total | revenue external | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| —segment total | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥228,000 |
| —segment total | segment profit | 2022-06-01 → 2022-11-30 | ¥374m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥228,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2022-11-30 | ¥376m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 493
| Item | Context | Value | Unit |
|---|---|---|---|
| Long term loans payable | Prior1YearInstant | 82622000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 68186000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 11065000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 14116000 | JPY |
| Other ncl | Prior1YearInstant | 6735000 | JPY |
| Other ncl | CurrentQuarterInstant | 3988000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 100423000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 86290000 | JPY |
| Liabilities | Prior1YearInstant | 1538340000 | JPY |
| Liabilities | CurrentQuarterInstant | 1539575000 | JPY |
| Capital stock | Prior1YearInstant | 286034000 | JPY |
| Capital stock | CurrentQuarterInstant | 286034000 | JPY |
| Capital surplus | Prior1YearInstant | 337314000 | JPY |
| Capital surplus | CurrentQuarterInstant | 337314000 | JPY |
| Retained earnings | Prior1YearInstant | 1710467000 | JPY |
| Retained earnings | CurrentQuarterInstant | 1803625000 | JPY |
| Treasury stock | Prior1YearInstant | -443718000 | JPY |
| Treasury stock | CurrentQuarterInstant | -443718000 | JPY |
| Shareholders equity | Prior1YearInstant | 1890097000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 1983256000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 2229000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 2229000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 24689000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 26660000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 26919000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 28890000 | JPY |
| Non controlling interests | Prior1YearInstant | 12002000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 16896000 | JPY |
| Net assets | Prior1YearInstant | 1929020000 | JPY |
| Net assets | CurrentQuarterInstant | 2029043000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 3467360000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 3568619000 | JPY |
| Net sales | Prior1YTDDuration | 1997979000 | JPY |
| Net sales | CurrentYTDDuration | 2342045000 | JPY |
| Cost of sales | Prior1YTDDuration | 1173877000 | JPY |
| Cost of sales | CurrentYTDDuration | 1455560000 | JPY |
| Gross profit | Prior1YTDDuration | 824101000 | JPY |
| Gross profit | CurrentYTDDuration | 886484000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 646282000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 716696000 | JPY |
| Operating income | Prior1YTDDuration | 177819000 | JPY |
| Operating income | CurrentYTDDuration | 169788000 | JPY |
| Interest and dividends income noi | Prior1YTDDuration | 378000 | JPY |
| Interest and dividends income noi | CurrentYTDDuration | 708000 | JPY |
| Gain on forfeiture of unclaimed dividends noi | Prior1YTDDuration | 53000 | JPY |
| Gain on forfeiture of unclaimed dividends noi | CurrentYTDDuration | 45000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 21420000 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 25189000 | JPY |
| Other noi | Prior1YTDDuration | 6969000 | JPY |
| Other noi | CurrentYTDDuration | 1892000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |